Brief: Amoeba Confirms New Development Phase Of Multi-Partner Tests In Biocontrol

Amoeba SA

29/04/2020 07:25

April 29 (Reuters) - Amoeba SA  AMEBA.PA :
    * WITH 8 RESEARCH PARTNERSHIPS IN BIOCONTROL, AMOEBA
CONFIRMS A
NEW DEVELOPMENT PHASE
    * PURPOSE OF THESE RESEARCH PARTNERSHIPS CONSISTS IN
PROVIDING
EXPERIMENTAL PRODUCTS (IN VARIOUS FORMULATIONS) CONTAINING
AMOEBA LYSATE WILLAERTIA MAGNA C2C MAKY
    * AGROCHEMICAL GROUPS WILL FINANCE AND CARRY OUT THEIR OWN
FIELD
TESTS ACROSS EUROPE TO ASSESS PRODUCTS PERFORMANCE IN PREVENTING
DISEASES ON DIFFERENT CROPS
    * FIRST MARKETING AUTHORIZATIONS COULD BE ISSUED IN 2022 IN
UNITED
STATES AND 2024 IN EUROPE
    * THREE OR FOUR PARTNERS SHOULD BE SELECTED TO MOVE TO THE
NEXT
PRODUCT DEVELOPMENT AND COMMERCIALIZATION PHASE
    * TESTS, CARRIED OUT BY AMOEBA, ARE FINANCED THROUGH THE NEW
OCA
(CONVERTIBLE BOND) ISSUE CONTRACT WITH NICE & GREEN OF €6.240
MILLION

Source text : https://bit.ly/2xiLnCL
Further company coverage:  AMEBA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))